NewAmsterdam Pharma Company N.V.

NAMS

Market cap$4.16 B

Rank#1563

Filings386

NewAmsterdam Pharma Company N.V. has filed 386 public company documents between 2022 and 2026. The most frequent type is insider trade (101 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchNAMS overview$4.16 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #1563See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut NAMS beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow NAMS via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
PRE 14A	PRE 14A	2mo ago2026-04-20	2026-04-20	View filing
PRE 14A	PRE 14A	1y ago2025-04-28	2025-06-04	View filing
PRE 14A	PRE 14A	2y ago2024-04-29	2024-06-05	View filing

NewAmsterdam Pharma Company N.V.

Similar companies to research next

Year